12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Plan B One-Step levonorgestrel tablet 1 regulatory update

HHS Secretary Kathleen Sebelius overruled an FDA recommendation and directed the agency to issue a complete response letter for a label revision to make emergency contraceptive Plan B One-Step levonorgestrel available without a prescription to women of child-bearing potential 16 years and younger. The drug is approved...

Read the full 213 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >